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Background: Mental health problems are highly frequent, as well as being associated
with enormous societal and economic costs and significant disability-adjusted life years.
Children of parents with a mental illness (COPMI) are at a tremendously increased risk
to develop disorders themselves. According to the literature, parental mental disorders
launch a wave of risk factors that in turn predict the emergence of psychological problems
in the offspring, and effective treatment of the parental disorder has been associated with
reduced child psychopathology (launch and grow assumption). Furthermore, studies
focusing on parent-child interaction demonstrate generally poorer parenting skills in
parents with mental disorders, and the enhancement of such skills has been a significant
mediator in improving child outcomes (parenting assumption).
Objective: To implement a preventive intervention for COPMI with the aim of interrupting
the transmission of mental disorders in children of a parent with mental disorders. An RCT
will compare state-of-the-art cognitive behavioral therapy (CBT) for a parent with mental
disorders to CBT plus the Positive Parenting Program (Triple-P), a well-established and
evidence-based program that enhances parenting skills.
Methods: A total of 634 patients seeking treatment in 8 outpatient clinics in Germany
and their children will be included between January 2018 and April 2021 in the study.
We use (clinical) interviews and self- as well as other-report questionnaires to assess
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the families at four main measurement points [T1: beginning of waiting period for
psychotherapy treatment (duration of waiting period depends on usual waiting period
in the study center: multiple baselines), T2: begin of parental psychotherapy, T3: post-
assessment, T4: 6 months follow-up]. The total observation period will be 39 months.
The patients will be randomly assigned to either the control condition (25 to 45 CBT
sessions) or the experimental condition (25 to 45 CBT sessions + 10 Triple-P sessions).
For evaluating the treatment process, the patients and clinicians will also be assessed
after each treatment session. Furthermore, there will be a continuous assessment and
report of adverse events during treatment.
Discussion: This trial will be the first ever to address the launch and grow as well
as the parenting assumption in one study and to establish effects of the two different
interventions on children’s health. Our study will also likely be the first one to provide data
on the comparative cost-effectiveness and will therefore provide essential information
relevant for the potential implementation of such programs. The structure of the RCT
will allow us to establish effects of the parental disorder(s) with/without comorbidities
on children’s health, to test assumptions of the trans-generational transmission model of
mental disorders and bi-directional influences of different treatments on the model and to
analyze specific transmission mechanisms. A deeper understanding of risk mechanisms
will reveal specific transmission profiles that will result in the early detection of and effective
reduction in risk factors and thus improve the health of the children at risk.
Ethics: The study is carried out according to the GoodClinical Practice (GCP) guidelines,
the Declaration of Helsinki and its later supplements and local legal requirements. The
lead ethics committee at the department of psychology at Philipps-University Marburg
approved the study procedure and all study documents. A positive ethics committee
vote is required at a study site, before the inclusion of a first patient at the respective site.
Dissemination: Via peer-reviewed publications in scientific journals, the results of this
study will be made available to the scientific community. Using PsychData all primary data
will be made available for re- and meta-analyses. Politicians, public health services, and
stakeholders will be informed throughout the study and beyond, thus, improving public
policy and health care decisions concerning preventive interventions and treatments
for COPMI.
Trial Registration: DRKS-ID: DRKS00013516 (German Clinical Trials Register,
https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=
DRKS00013516)
Keywords: children ofmentally ill parents, transgenerational transmission, randomized controlled trial, prevention,
intervention, mental disorders, parenting training
INTRODUCTION
Children of mentally ill parents (COPMI) are at a high risk
of developing severe mental illness (SMI) themselves and are
likely to be the next generation of mentally ill patients (1).
There are studies pointing to the fact, that the parental mental
disorder launches a wave of risk factors that in turn predict
the emergence of psychological problems in the offspring (2).
Numerous studies have shown that a parental mental illness is
a powerful risk factor for the development of a SMI in children
(OR in the BELLA study of 2.4) (1, 3–8). Long-term studies
were also able to show that COPMI have a higher life-time risk
of developing SMI themselves (ranging from 41 to 77%) with
subclinical symptoms emerging earlier and more often (5, 6).
The treatment of the parental disorder has been associated with
improved outcomes in COPMI (7, 9–13), although there are
few studies on such effects (7, 14), and they typically target the
same symptoms in the child as the parent’s, while such specific
transmission of disorders is not typical for COPMI (1). A recent
meta-analysis (k = 9) by Cuijpers et al. (14) on the effects of
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psychological treatment of maternal depression on children’s
psychopathology resulted in an overall effect-size of g = 0.40.
However, the studies included were very heterogeneous (k = 5
targeting women with post-partum depression; k = 4 targeting
pregnant women or mothers of young children or mothers of
children with psychological/psychiatric problems/disorders), and
only 2 studies explicitly applied Cognitive Behavioral Therapy
(CBT) as an intervention that resulted in an overall effect of
g = 0.31 (14). An earlier meta-analysis by Siegenthaler et al.
(15) on preventive interventions for children of mentally ill
parents demonstrated a significant relative risk reduction of 40
% for the same disorder as the parents’, and overall small effects
for children’s internalizing (g = −0.22) and externalizing (g =
−0.16) symptoms. This analysis included interventions targeting
children though and not specifically those that assessed parental
psychotherapy effects on their children (15). Our own meta-
analysis on preventive interventions for COPMI (16) resulted in
effect sizes similar to those of Cuijpers et al. (14) for young (up
to 5 years of age) children (g = 0.31), and overall smaller effects
for older children (g = 0.14) that equal those of Siegenthaler
et al. (15). Different longitudinal studies on parental anxiety and
depressive disorders present heterogeneous effects of parental
treatment on children. A 6 year prospective longitudinal study
on the effects of parental panic treatment demonstrated that
parental treatment is a significant predictor of children’s anxiety
symptoms (d= 0.49–1.09 for different parental psychopathology
predictors) (7). The Sequenced Treatment Alternatives to Relieve
Depression (STAR∗D) Child study was designed to examine
the relation between maternal remission from depression
and children’s functioning and psychopathology. The study
demonstrated differential effects on child psychopathology in
early, late, and non-remitting mothers, with early remission
being associated with reduced child externalizing problems (∼5%
of Child Behavior Checklist (CBCL) externalizing symptoms
explained) (13); similar results have been obtained in another
large longitudinal study (9).
Studies focusing on the parent-child interaction tended to
demonstrate poorer parenting skills in parents with mental
disorders (17–20). The enhancement of such skills has been
identified as a significant mediator in improving child outcomes
(21). The Positive Parenting Program (Triple P) is a well-
established program to enhance parenting skills in parents of
children aged 0–16 years (Triple P Kids and Triple P Teens).
Universal prevention effects have been established for the Triple
P Kids program (22), as well as specific effects for child
psychopathology (d = 0.473) (23, 24) that differ for mothers (d
= 0.61) and fathers (d = 0.42). The effectiveness of the Triple P
Teen program was also shown (25). Studies explicitly testing the
parenting assumption in conjunction with the launch and grow
assumption are lacking so far.
Regarding psychotherapy research, there have been
suggestions that moving from an approach comparing an
active treatment with a control group (“does it work?”) to one
that examines putatively active treatments resulting in relative
questions (“which works best?” or “how do the treatments
differ?”) is advisable. If demand artifacts and differentiating
non-specific from specific treatment factors are included, we
arrive at this formula: Treatment A = E + DT + TNS + TS(A)
and Treatment B = E + DT + TNS + TS(B) with E = all
extraneous factors; DT = demand characteristics treatment; TNS
= non-specific treatment factors; TS = characteristic-specific
treatment factors. Thus, the relative difference between the two
active agents in the proposed study TS(A) = CBT and TS(B) =
CBT+PPP estimates how the two treatments differ and enables
us to determine relative effects (26). Such head-to-head studies
on preventive interventions for COPMI assessing differential
effects have been extremely rare; the classic format are “does it
work?” studies (15).
Thus, we aim to implement a preventive intervention for
COPMI with the aim of interrupting the transmission of mental
disorders in children of a parent with a mental disorder. The
preventive intervention is planned as a two-arm RCT to establish
whether strengthening parenting skills results in incremental
COPMI effects above and beyond state-of-the-art CBT for
parents. Including an economic evaluation alongside the clinical
trial, the results of this study will have an effect on the decision
making process on resource allocation for this highly vulnerable
group of children of mentally ill parents.
The RCT will thus target the following hypothesis: (1) the
treatment of the parental disorder will result in improved child
outcome (1st arm: CBT) (2, 7, 12), and (2) the parenting skills
of parents with mental illness are impaired and enhancing
such skills leads to better child outcomes, thus incremental
effects will become apparent in the 2nd arm: CBT+Triple P
(17, 18, 20, 27, 28).
Further research questions are: Is the clinical outcome
associated with reduced direct medical, direct, and indirect non-
medical costs? Are CBT and CBT+PPP associated with improved
quality of life for parents and children? Are CBT and CBT+PPP
associated with increased psychopathology knowledge of parents
and children? Is CBT+PPP associated with higher parenting
skills than CBT alone? Are the effects independent of type of
diagnosis, comorbid disorders, and psychopharmacology?
METHODS
Design
The planned study is a prospective, multicenter, confirmatory,
randomized controlled phase III-trial with two parallel arms
comparing the effects of state of the art CBT (control
intervention), and CBT + Triple P (experimental intervention)
for parents with a mental illness on their children. The study
is coordinated by the Department of Psychology, Clinical
Child-, and Adolescent Psychology at the Philipps University
Marburg (UMR).
After 3 months of study preparation (October–December
2017), a 15 months recruiting period has started in January 2018.
The assessment period (first patient in until last patient out) will
last for a total of 39 months. Six months are scheduled for data
freeze, data cleaning and analysis. Thus, the duration of the whole
trial is 48 months (see Figure 1).
Using the same instruments (self- and other-report
questionnaires as well as (clinical) interviews) each time,
patients, and their families will be assessed at four main
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measurement points (see Figure 2): pre-assessment 1 (T1,
beginning of waiting period for psychotherapy treatment
(duration of waiting period depends on usual waiting period
in the study center: multiple baselines), pre-assessment 2, (T2,
beginning of parental psychotherapy), post-assessment (T3,
after parental psychotherapy), follow-up-assessment (T4, 6
months after parental psychotherapy). Altogether, assessment
time comprises between 4 and 5 h for each main assessment
(T1, T2, T3, T4) for each family. Patients and therapists are
also assessed after each treatment session for treatment fidelity
and satisfaction. Every fifth session, the remission status of the
patient is also assessed.
Participants
A total of 634 parents with a mental illness (patients) shall be
included in the study. The following criteria must be met for
patients and their families to be included in the study: (1) patient
seeks outpatient psychotherapeutic care, (2) patient currently
meets diagnostic criteria for DSM-5 disorder (29), and (3) patient
is caring for at least one child between the ages of 1.5–16 years.
Patients and their families will not be included in the study if
(1) patient is already in psychotherapeutic treatment, (2) patient
needs acute inpatient treatment (e.g., acute risk of committing
suicide or acute psychosis), (3) all children fulfill criteria for
a severe mental illness and are in need of prompt treatment,
(4) patient uses benzodiazepines continuously (intermittent drug
use less than once every 2 weeks is allowed), or (5) family
has insufficient German language skills. No further exclusion
criteria will be applied. Hence, we seek to establish effects of
parental psychotherapy on children in a naturalistic setting and
want to specify the effects of the transgenerational transmission
to test the launch and growth assumption. Patients in need of
acute inpatient treatment are referred to cooperating hospitals.
For children in need of prompt care, treatments are initiated
at the study sites or the families are referred to other local
specialists/psychiatric hospitals.
The study will be conducted at eight university outpatient
clinics throughout Germany: Bielefeld, Bochum, Gießen,
Landau, Leipzig, Mainz, Marburg, and Munich. All cooperating
sites have established outpatient clinics for research and teaching
as well as psychotherapy training institutes and are well-known
specialized treatment centers for psychotherapy. The patients
are primarily recruited from the university outpatient clinics at
each study site. The study centers have continuous experience
in conducting psychotherapy studies with recruitment of large
patients numbers (30, 31). The patients to be recruited per
center and fulfilling all inclusion criteria will be attainable over a
15-month acquisition period at all study sites without the need
to change the existing infrastructure. If possible, all children
between 1.5 and 16 years of age (at T1) and a partner living
together with the family shall be included in the study. A legal
guardian not living together with a child can upon request be
offered to participate in the study and to complete questionnaires
about the respective child. Inclusion only takes place if the family
participates voluntarily in the study. There is no compensation
for study participation.
Interventions
All patients will receive between 25 (short-term) and 45 (long-
term) weekly or bi-weekly sessions of individual state of the
art Cognitive Behavioral Therapy (CBT). A high frequency
therapy with more than one session per week is also allowed.
Depending on the amount and the frequency of therapy sessions,
the treatment will usually last between 6 and 12 months. The
number of sessions and therapy duration will be documented,
thus, allowing us to include therapy duration and number of
sessions as a moderating factor in the analyses.
CBT can be considered the current “treatment of choice”
for mental disorders in general (32). Central elements are
psychoeducation that provides a framework for psychotherapy,
cognitive components (i.e., debate of dysfunctional cognitions
alias Beck), as well as behavioral interventions (i.e., exposure).
As all study sites are outpatient clinics for research and teaching
located at university psychology departments, they commit to the
highest possible state of the art standard for CBT as outlined in
“proceedings in psychotherapy/Fortschritte der Psychotherapie”
of which Prof. Rief (Co-PI of COMPARE-family) is an editor
(33). As the study shall be conducted as naturalistic as possible
and a broad range of disorders shall be included, no specific study
manual has been created, rather, the respective therapy manuals
of the proceedings in psychotherapy will be used in this study.
Patients randomized to the experimental group will receive
8–10 additional group or individual sessions of the Positive
Parenting Program (Triple P) parallel to the last third of
the psychotherapy sessions to test whether the enhancement
of parenting skills will result in improved child outcome, as
suggested in different studies (17, 18, 20, 27, 28), above and
beyond parental CBT. Triple P is a well-established, widely used
and evidence-based program to enhance parenting skills. The
Triple P Kids program can be used in groups or individual
sessions with parents of children aged 0–12 years (34, 35)
and the Triple P Teens program in groups with parents of
children aged 12–16 years (36). The Triple P elements are: (1)
promotion of a positive parenting style, (2) promotion of child
development, (3) dealing with problem behavior, (4) behavior
training sessions (34–36).
Outcomes
Primary Outcome Measure
The primary outcome is the children’s pathology according to the
[(Caregiver-) Teacher Report Form (C-)TRF, caregiver/teacher
version of the Child Behavior Checklist] score between baseline
2 (T2) and post treatment (T3) as well as between T2 and the
6-month follow-up (T4) after end of treatment (37, 38) as the
literature shows that mentally ill parents can be biased in rating
their children’s symptoms (39). Further, teacher ratings have
been shown to demonstrate greater predictive validity in the
long term ratings (40). In comparison to shorter questionnaires
[e.g., Strengths and Difficulties Questionnaire (SDQ) (41)], the
CBCL also produces more variance. As the CBCL is used in
various studies as a primary outcome measure (15), we will be
able to compare our data to a broad range of other results.
Further outcome measures are mental disorders according
to the Diagnostic Interview of Mental Disorders for parents
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FIGURE 1 | Study design.
FIGURE 2 | Study assessment points. *Waiting period can vary according to the regular waiting period in the study centers.
and children (DIPS and Kinder-DIPS) (42–44) respectively for
children under the age of 6 years the Structured Interview for
Preschool Ages (SIVA) (45) and the parent rating of the children’s
pathology according to the CBCL (for detailed descriptions see
below). Thus, we will be able to validate the teacher ratings with
the Kinder-DIPS diagnoses and can compare the concordance of
the teacher and parent ratings.
Secondary Outcome Measures
Children’s and parents dimensional severity index of a broad
range of mental disorders according to the DSM-5 based
clinical interview (Kinder-)DIPS (42–44) respectively the
SIVA (45), parent’s psychopathology according to the Brief
Symptom Inventory (BSI) (46), personality traits (PID-5-BF)
(47), children’s psychopathology according to the CBCL-
parentversion (37, 38), parenting skills (EFB) (48), parental
stress (ESF) (49), children’s and parents knowledge about mental
disorders [semistructured interview adapted from Beardslee
and Röhrle, (50)], direct medical costs and direct and indirect
non-medical costs (TiC-P) (51), health-related quality of life in
parents [EuroQoL/EQ-5D-5L, AQoL-8D (52, 53)], health-related
quality of life in children (KIDSCREEN-10) (54, 55) (for details
see Table 1).
Instruments
The (Kinder-) DIPS is a diagnostic interview for mental disorders
and is available for the diagnoses of mental disorders from age
6 to adulthood according to ICD-10 and DSM-5. The SIVA is
a diagnostic interview for mental disorders for preschool ages
according to ICD-10 and DC: 0–5. A translation table to DSM-5
diagnoses has been created for this study. For parents we use the
DIPS; for their children the Kinder-DIPS or SIVA. Conducting
the interviews with the patient takes around 60–90min as well
as the child assessment with the Kinder-DIPS or SIVA for each
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TABLE 1 | List of diagnostic domains and measurements.
Who? Where? T1 T2 Intermediate T3 T4
Eligibility screening Family Local x
Socio-demographics Parents Local x
Structured clinical interview with the patient (DIPS) Patient Local x x x x
Structured clinical interview for children (Kinder-DIPS/SIVA) Parent Local x x x x
Brief Symptom Inventory (BSI) Parents Online x x x (patient) x x
Personality traits (PID-5-BF) Parents Online x x x x
Child Behavior Checklist (CBCL) Parents Online x x x x
(Caregiver-) Teacher Report Form [(C-)TRF, caregiver/teacher version of the CBCL] Teacher Online x x x x
Parenting Skills (EFB) Parents Online x x x x
Parental Stress (ESF) Parents Online x x x x
Knowledge about mental disorders Parents, children Local x x x x
Direct and indirect costs in children and parents (adapted TiC-P) Parents Online x x x x
Health-related quality of life in parents (EuroQoL/EQ-5D-5L, AQoL-8D) Parents Online x x x x
Health-related quality of life in children (KIDSCREEN-10) Parents, children (>8) Online x x x x
(Serious) adverse events Parents, children Local x x (patient) x x
Psychopharmaka and other drugs Parents, children Local x x x x x
Concomitant interventions Parents, children Local x x x x x
child. Different studies have shown good quality criteria for these
interviews (43, 45).
The Achenbach System of Empirically Based Assessment
(ASEBA) (56) consists amongst others of questionnaires for
preschool (C-TRF and CBCL 1,5-5, consisting each of 100
problem items) and school-ages (TRF and CBCL, consisting each
of 113 problem items). Answers are rated on a three point Likert-
scale (0 = Not true to 2 = Very True or Often True) and
can be scored on different subscales, the second order scales
internalizing problems and externalizing problems as well as on
a total problem scale. Studies have reported good to very good
internal consistency with r > 0.86 for the second order scales
and the total problem scale of the preschool age-versions (37)
and Cronbach’s alpha >0.80 for the second order scales and at
least.93 for the total problem scale in the school age-versions (38).
In the current study we use the parent (CBCL) and teacher (TRF)
ratings of the ASEBA.
The Brief Symptom Inventory (BSI) is a self-report
questionnaire consisting of 53 items that are rated on a five
point Likert-scale (0 = not at all to 4 = very much). Answers are
scored on nine Primary Symptom Dimensions and three Global
Indices. Internal consistency with Cronbach’s alpha > 0.70 for
the subscales and > 0.90 for the Global Indicee GSI is good to
very good (46).
The Personality Inventory for DSM-5-Brief Form (PID-
5-BF) is a self-report questionnaire assessing 5 personality
traits (negative affect, detachment, antagonism, disinhibition,
and psychoticism). The 25 items are rated on a 4 point
Likert-scale (0 = very false or often false to 3 = very true
or often true). An average score for each domain and an
overall score can be calculated with higher scores indicating
greater dysfunction. The average domain and overall personality
dysfunction scores were found to be reliable in the DSM-5 Field
Trials (47).
The Elternstressfragebogen (ESF) is a German self-report
questionnaire with 38 items assessing parental stress. The
answers are rated on the four scales Parental Stress, Role
Restriction, Social Support, and Partnership. The internal
consistency is good with Cronbach’s alpha > 0.76 (49).
The Erziehungsfragebogen (EFB) is the German adaptation of
the English Parenting Scale (57). The self-report questionnaire
consists of 35 items and can be rated on the scales Overreactivion,
Laxness, and Verbosity as well as on a total score. The internal
consistencies of the scales Overreaction, Laxness, and the total
score is acceptable to good with Cronbach’s alpha > 0.74. For
Verbosity the internal consistency is lower with Cronbach’s alpha
> 0.59 (48).
To assess knowledge aboutmental disorders, a semi structured
interview was adapted from Beardslee and Röhrle (50). Domains
of the interview are knowledge about mental disorders in general,
knowledge about the primary diagnosis of the mentally ill parent,
causes of the mental illness, coping with the mental illness and
communication. Conducting the interviews separately with all
family members over the age of 6 years takes 15min each.
The questionnaire on healthcare consumption and
productivity losses for patients with a Psychiatric disorder
(TiC-P) is a comprehensive and widely used self-report
questionnaire focusing on establishing direct medical costs
and indirect costs (e.g., productivity losses due to absenteeism
and presenteeism) (51). The TiC-P is a feasible and reliable
instrument for collecting data on medical consumption and
productivity losses in patients with common mental health
conditions (58). The TiC-P has been previously adapted for use
in Germany (59). For this study, we adapted the TiC-P for use
in children.
The EQ-5D-5L is a widely used instrument to calculate
quality-adjusted life years (QALYs) (52). The EQ-5D-5L
comprises 5 items covering 5 domains (mobility, self-care,
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usual activities, pain/discomfort, and anxiety/depression),
each of which is rated as causing “no problems,” “slight
problems,” “moderate problems,” “severe problems,” and
“extreme problems.” Theoretically, the EQ-5D-5L generates
3,125 different health states. Preference-based utilities for each
of these health states are available for Germany with “full health”
and “death” being anchored at 1 and 0, respectively (60).
The Assessment of Quality of Life (AQoL) instruments are
health-related multi-attribute utility quality of life instruments.
The AQoL is a reliable and valid instrument (53). The
AQoL-8D consists of five psycho-social and three physical
dimensions. With one exception (dimension “senses”), each of
these represents a psychometrically valid sub-scale [e.g., tests
indicate they measure a common construct (61)]. Utility scores
were obtained by a four-stage methodology (62).
The KIDSCREEN-10 index consists of 10 items each
answered on a 5-point Likert scale. The index provides a
good discriminatory power along the health-related quality
of life trait-continuum. The KIDSCREEN-10 Index shows
good psychometric properties (63). Utility scores will be
derived by an algorithm for mapping the KIDSCREEN-10
index onto the CHU9D utility scores, a preference-based
instrument developed specifically for application in cost-utility
analyses (54).
Sample Size
The sample size calculation is based on the primary outcome
measure (change in TRF score between T2 and T3) which is
hierarchically ranked on top of the multiple testing procedure.
Based on the results described above (14, 15, 64), it is assumed
that the standardized treatment effect for this outcome expressed
by Cohen’s d amounts to d= 0.25. With a two-sided significance
level of α = 0.05 and a power of 1–β = 0.8 using a two-
sample t-test, 253 patients per group (n = 506 in total) are
required. Since the primary outcome is measured on the child
level and it is possible to enroll multiple children per patient,
a hierarchical multi-level model with patients at level 1 and
children at level 2 will be fitted. Taking a drop-out rate of 20
% into account, n = 634 patients need to be enrolled into
the trial in the analysis. This attrition rate is conservative and
based on results from the longitudinal STAR∗D study that also
carried out long-term follow-up assessments (13), as well as
on other studies in the field that report even lower attrition
rates (65, 66). The problem of attrition and missing values will
also be addressed in the analysis by applying the intention-to-
treat principle. For missing values, imputation techniques will be
applied, thus partly resolving this problem. Since it is assumed
that parts of the outcome variance can be explained by the
inclusion of covariates, the actual power of the analysis by a
linear multi-level model is expected to be higher than 1–β =
0.8. Assuming that the number of children enrolled per patient
amounts to 1.5, we expect that n = 950 children will participate
in the trial. The enrollment of more than one child per patient
is expected to yield an additionally increased power. Sample
size calculation was performed using SAS v9.4 (SAS Institute,
Cary, NC).
Randomization
Patients will be assigned in a 1:1 ratio to either the
control intervention (CBT) or the experimental intervention
(CBT+Triple P) through a centralized web-based tool (www.
randomizer.at). Randomization will be performed stratified by
center, comorbidity (yes/no), and total number of children
(1/more than 1). To achieve equal group sizes per stratum
block randomization will be performed. The block length will be
defined by the study biometrician and treated confidentially to
prevent selection bias.
Blinding
Assessment interviews will be conducted and analyzed by
clinician-raters blinded to the treatment condition. Raters at
post and follow-up assessments must not be the therapist of the
particular patient being assessed and analyzed.
Statistical Methods
Our primary efficacy analysis will be based on the full analysis
set (FAS) according to the intention-to-treat (ITT) principle,
reflecting the recommendations given in relevant guidelines (67).
The FAS is defined to include all patients enrolled who are
assigned to the treatment group they were originally randomized
to, regardless of whether they actually underwent the assigned
treatment or not. This will be the primary population for
evaluating all efficacy endpoints and subject characteristics.
Additionally, the per-protocol (PP) population, including all
FAS patients with no major protocol deviations, will serve as
a secondary analysis population and be used for sensitivity
analyses. Before lock of the database, each patient’s allocation
to the FAS or PP population will be defined in the statistical
analysis plan.
The two hypotheses to be assessed in the primary efficacy
analysis are ordered hierarchically: In the first step, the null
hypothesis HI0: µ
T3−T2
CBT+PPP = µ
T3−T2
CBT for the primary outcome
“change in teacher CBCL (Teacher Report Form/TRF) score
between T2 and T3” is tested at the two-sided significance level
of 5% against the alternative HI1: µ
T3−T2
CBT+PPP 6= µ
T3−T2
CBT . If H
I
0 can
be rejected, the null hypothesis HII0 : µ
T4−T2
CBT+PPP = µ
T4−T2
CBT for the
second primary endpoint “change in TRF score between T2 and
T4” is tested at the two-sided level of 5% against its alternative
HII1 : µ
T4−T2
CBT+PPP 6= µ
T4−T2
CBT . Application of this multiple test
procedure for a priori ordered hypotheses ensures control of the
family-wise type I error rate at a level of 5%. The null hypotheses
will be assessed using a linear mixed multi-level model with
patients at level 1 and children at level 2, adjusting for center,
number of comorbidities, number of children, baseline TRF score
at T2, and length of waiting period between T1 and T2 (in weeks).
Data missing for the primary outcome variable will be
replaced by using multiple imputation (68) which takes the
covariates treatment group, center, number of comorbidities,
number of children, baseline TRF score at T2, and length of
waiting period between T1 and T2 (in weeks) into account by
applying the fully conditional specificationmethod (69). This will
be realized using the option “FCS” of the SAS “MI” procedure
implemented in SAS 9.4. Sensitivity analyses will be performed by
applying alternative methods dealing with missing data such as
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complete case analysis. All secondary outcomes will be evaluated
descriptively, and descriptive p-values are reported together with
95% confidence intervals for the corresponding effects. Further
exploratory analyses will be performed to identify potential
prognostic factors (e.g., parental disorder, child psychopathology,
socio-economic status) and mediators (e.g., Brief Symptom
Inventory/BSI, Parenting Questionnaire/EFB, Parental Stress
Inventory/ESF) for an intervention effect. The safety analysis
includes calculation of frequencies and rates of adverse and
serious adverse events together with 95% confidence intervals. All
analyses will be performed with SAS version 9.4 or higher.
The health-economic evaluation will involve a combination
of a cost-effectiveness analysis (CEA) and a cost-utility analysis
(CUA) (70, 71). The economic evaluation will be done from
a societal perspective (all relevant costs) and a public health
care perspective (only direct medical costs) within a 6 month
time frame. In the CEA, the incremental cost-effectiveness ratio
(ICER) will be expressed as the incremental costs per point
improvement on the primary clinical outcome (CBCL scores
in children; parents’ BSI scores). In the CUA, the ICER will
be expressed as incremental costs per quality-adjusted life year
(QALY) gained as based on the EQ-5D-5L (52, 72) (parents)
and KIDSCREEN-10 (63, 73) (children). Sampling uncertainty
in the ICER will be handled using non-parametric bootstrapping
by resampling patient-level data to generate 2,500 simulations
of the ICER. We will bootstrap the SURE model (seemingly
unrelated regression equations; sureg command in Stata) to allow
for correlated residuals of the cost and effect equations (74).
Ninety five percent confidence intervals (CI) will be obtained by
the bootstrap acceptability method, since parametric techniques
are inappropriate for use on skewed variables and ratios (75).The
bootstrapped ICERs will be plotted in a cost-effectiveness plan
where the horizontal axis reflects differences in effects and the
vertical axis differences in costs. The bootstrapped ICERs will
also be shown in a cost-effective acceptability curve disclosing
the probability that the intervention is cost-effective for a range
of willingness-to-pay ceilings (76). To test the robustness of
the base-case findings, a probalistic sensitivity analysis will be
done. Several assumptions made in the base-case scenario will
be changed to assess their impact on the ICER (e.g., QALY
calculation based on AQoL-8D).
DATA MANAGEMENT, MONITORING, AND
QUALITY ASSURANCE
Training of Study Personal and Treatment
Fidelity
All study personal (assessors, therapists, and supervisors) will
be trained before taking part in the study. As all sites are
part of associated university training institutes that conform
to the highest psychotherapeutic standards. All therapists will
receive intense training in CBT for the different disorders.
The Triple P institute in Münster, which is the official and
certified Triple P institution in Germany, will carry out Triple
P training. Trained and certified supervisors will supervise every
fourth treatment session at the study sites. At each participating
center, a clinical project manager is responsible that the study
is conducted in accordance to the procedures outlined in the
study protocol. Concerning all information and data collected
during the study, all study personal maintain professional secrecy
and confidentiality.
After each treatment session, the therapists indicate CBT
adherence by rating a checklist extracted from the disorder
specific therapy manuals as outlined in the proceedings in
psychotherapy (33). Upon termination of a study therapy, a
supervisor rates the overall adherence of the therapy based on the
adherence checks completed after every session. The adherence
rate is documented in the eCRF for further analyzes.
Treatment fidelity/integrity will be analyzed with rating
schemes for 5% randomly selected videotaped treatment sessions
by the study coordination at the UMR. Before the videotapes
are rated; they will be checked for any cues/hints potentially
indicating the treatment condition; those will be erased.
Data Collection and Retention
For each included family, a study file will be created at the study
site in which all local study documents will be archived. An
electronic case report form (eCRF) will be used for the data
collection using the secure web based electronic data capture
(EDC) tool REDCap (77). The participants complete most of
the questionnaires directly in the eCRF. A study staff at each
site creates log-in-codes that are handed out to the participants
during on site sessions with which the participants (parents,
children over the age of 8 years and caregivers/teachers) can
log into REDCap to complete the questionnaires at home. The
families are asked to fill out the forms independently. The eCRF
is programmed to not allow skipping answers to prevent missing
data. If questions occur, filling out the eCRF can be paused and
continued later on with a trained assessor at a study site. A study
staff will enter locally collected data into REDCap preferably on
the day of data collection. Upon termination of the study, all
local study documents at the study sites will be sent to the UMR
where the documents will be digitalized. For supervision and to
ensure treatment fidelity, all study sessions will be videotaped.
The video data will be stored in encrypted form using VeraCrypt
which is useable free of cost under the Apache License 2.0. All
videotapes will be send to the study coordination at the UMR
and stored there. Upon termination of the study, all video data
will be destroyed.
All local study documents are part of the Investigator Site
File (ISF) as outlined in section 8 of the ICH Consolidated
Guideline which is stored and archived according to the legal
retention period. Data quality assessment of the eCRF will
be done continuously by the Institute of Medical Biometry
and Informatics Heidelberg during the study. Any entry and
correction in the EDC system will be documented automatically
in an audit file. Completeness, validity, and plausibility of data
will be checked in time of data entry (edit-checks) and using
validating programs which will generate queries. All assessments
and modifications are immediately accessible via web access. The
clinical project manager at each study site is also responsible for
online transmission of data and site-specific quality assurance.
Upon completion of the study, all data will be exported into
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different data formats for further analyses. The primary data
will be made accessible to the public for re- and meta-analyses
through PsychData at the Leibniz Institute for Psychology
Information (https://www.psychdata.de/). All data will be used
in accordance to data protection regulations and the data safety
guidelines of the German Psychological Society (DGPs).
Ethical and Legal Aspects
Working with a highly vulnerable group, the procedures set
out in this study protocol are designed to ensure that the
investigators abide by the principles of the Good Clinical
Practice (GCP) guidelines of the International Conference on
Harmonization (ICH) and the Declaration of Helsinki and
its later supplements. The study will be carried out adhering
to local legal requirements. The lead ethics committee at the
department of psychology at the UMR has approved the study
procedure, study information, and informed consent forms in
December 2017 and its subsequent amendments in May and
July 2018. A positive ethics committee vote is required at a
study site (ethics committees at the departments of psychology
at Bielefeld University, Ruhr-University Bochum, Justus Liebig
University Giessen, University of Koblenz-Landau, University
of Leipzig, Johannes Gutenberg University Mainz, and Ludwig-
Maximilians-University Munich), before the inclusion of a first
patient at the respective site. At the beginning of the study,
patients and their families are informed verbally and written
about the aims of the study and the study procedures. All patients
and their families (children over 6 years of age) need to provide
written informed consent for study participation. For children
to participate in the study, written informed consent by all legal
guardians is required. Every participant can drop out of the study
at any time. All dropouts will be documented in the eCRF.
Pseudonymization
After signing the informed consent, each study participant
is assigned a pseudonymized screening-ID. The screening-ID
consists of three parts: specific number for the study site,
consecutive screening number and individual coding number (1
= patient, 2 = partner, 3, 4, 5 = included children in order of
increasing age, X = ex-partner). Members of a family can be
recognized by the first two parts of the screening-ID (specific
study site number and consecutive screening number).
There is a coding list on paper at each study site on which
names and screening-IDs are documented. The coding lists,
which are kept locked away, are accessible only to study personal.
The lists will be destroyed upon termination of the study but
no later than 2021/12/31. After that, all data will be fully
anonymized. As long as the coding lists exist, participants can
request the deletion, respectively the destruction of all their
collected data.
Clinical Monitor
A clinical monitor is responsible for overviewing the
implementation of the study in accordance to the ICH-GSP
guidelines at the study sites. The clinical monitoring includes
pre-study, initiation, intermediate and close-out visits to the
study sites. During the site visits, the clinical monitor examines
the protocol adherent study implementation, the safety of the
patients and the data consistency (e.g., comparison of local study
documents and eCRF records).
Data Safety Monitoring Board
An independent Data Safety Monitoring Board (DSMB),
consisting of a university professor, which is an expert in the field
of the study, and a biometrician, is responsible for monitoring the
study as well as assessing the study protocol adherence and the
study progress (especially the recruiting plan). The DSMB will be
informed about all safety aspects of the study (especially serious
adverse events, SAE) and will review them regularly. If necessary,
the DSMB will recommend changes to the study protocol or the
termination of the study.
DISSEMINATION
The results of this study will be made available to the larger
scientific community via peer-reviewed publications in open
access scientific journals. Politicians, public health services and
stakeholders will be informed through the COMPARE website,
conferences, teaching seminars, flyers, newsletters, and personal
contacts throughout the study and beyond, thus improving
public policy and health care decisions concerning preventive
interventions and treatments for COPMI. As all study sites are
university based outpatient clinics the implementation of results
in ongoing and future practice is ensured.
Upon termination of the study, all primary data will be
made available to the scientific community in a completely
anonymized manner for re- and meta-analyses using PsychData,
a data-sharing platform developed by the Leibniz Institute for
Psychology Information (ZPID, https://www.psychdata.de).
DETAILED STUDY PROCEDURE
A detailed flowchart of the study procedure is presented
in Figure 3.
Pre-assessment T1 and Assessment of
Eligibility
After an initial screening of eligibility for an as early and effective
as possible selection of patients and their families and a regular
intake consultation with the patient in the outpatient clinic, the
patients and their families (children over the age of 6 years)
are invited to an informational session at the study center.
During this session, the families are informed about the study
procedure before signing their consent to participate in the
study. For pseudonymized data collection, each participant is
assigned a Screening-ID. To assess a broad range of DSM-5 based
psychological disorders and comorbid ones as well as severity
ratings, structured clinical interviews for patients (DIPS), and
children (Kinder-DIPS parent version or SIVA) are conducted
with the patient respectively a parent (for each child separately).
The parent, with whom the Kinder-DIPS/SIVA is conducted, has
to be the same for all children of a family at all measurement
points. The in- and exclusion criteria are checked on the basis of
the information collected during the screening and the diagnoses
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FIGURE 3 | Study flowchart.
based on the clinical interviews. Feedback to diagnoses is given
in a separate session. If a patient and its family fulfill all the in-
and none of the exclusion criteria, the family is included in the
trial and records for the eCRF are created for all the included
family members. The family is invited to another session in
which interviews about knowledge about mental disorders are
conducted with each included family member. After this session
codes are handed out with which the family members can log
into REDCap at home to complete the questionnaires. Forms
with REDCap-codes for the children’s caregivers or teachers (one
caregiver/teacher for each included child) are also handed out
to the family with the request to forward them to the respective
caregiver/teachers. There is no reference to the clinical trial of
the COMPARE-family project on the caregiver/teacher’s form;
rather, the questionnaire is generally presented as part of a
study at the department of psychology the UMR. After the final
inclusion in the study, the randomization to one of the two
treatment arms (CBT or CBT+Triple P) takes place. If needed,
further probatory sessions can take place at the study centers.
In a separate feedback session, the patient is informed about the
treatment condition and results of the diagnostic process.
Pre-assessment T2
After the usual waiting period for a psychotherapy treatment
in the study centers (waiting period can differ between the
study centers depending on their usual waiting periods for
a psychotherapy treatment), structured clinical interviews for
patients and children are conducted again with the patient
respectively the same parent as in T1 (for each child separately).
The family is invited to another session in which interviews
about knowledge of mental disorders are conducted with each
included family member, and codes for logging into REDCap at
home to complete the questionnaires are handed out. The forms
with REDCap-codes for the children’s caregivers/teachers are also
handed out to the family with the request to forward them to the
respective caregivers/teachers.
Frontiers in Psychiatry | www.frontiersin.org 10 February 2019 | Volume 10 | Article 54
Stracke et al. COMPARE Family: Study Protocol
Treatment Period
All patients receive between 25 to 45 sessions of individual CBT.
Patients allocated to the experimental intervention (CBT+Triple
P) receive in addition 8 to 10 group or individual Triple P sessions
parallel to the last third of the CBT sessions. After every therapy
session, patients, and therapists complete a session-feedback
screener including aspects of therapeutic alliance and symptom
intensity, as well as on fidelity. (Serious) adverse events [(S)AE]
are also assessed after every therapy session with a checklist. If
a (S)AE occurs, a report has to be filed and send to the study
coordination at the UMR. Every fifth session, the patients are also
handed out a code for logging into REDCap at home to complete
the BSI to assess remission status (early, late, and non-remitters).
Post-assessment T3
Using the same measurements as in the pre-assessments, the
post-assessment is conducted by an assessor who is blind
to the treatment condition. Structured clinical interviews for
patients and children are conducted again with the patient,
respectively the same parent as in T1 (for each child separately).
During a separate session, interviews on knowledge about mental
disorders are conducted with each included family member
separately, (S)AE are assessed for every included family member,
and codes for logging into REDCap at home to complete the
questionnaires are handed out at the end. The forms with
REDCap-codes for the children’s caregivers/teachers are also
handed out to the family with the request to forward them to the
respective caregivers/teachers. If a (S)AE occurs, a report has to
be filed and sent to the study coordination at the UMR.
Follow-Up-Assessment T4
After a waiting period of 6 months, the follow-up-assessment
is conducted by a blind assessor in the same manner as the
post-assessment. The structured clinical interviews for patients
and children are conducted again with the patient respectively
the same parent as in T1 (for each child separately). In a
separate session, knowledge about mental disorders and (S)AE
are assessed for each included family member separately. At the
end of this session, codes for logging into REDCap at home to
complete the questionnaires are handed out. The forms with the
code for the children’s caregivers/teachers are also handed out
to the family with the request to forward them to the respective
caregivers/teachers. If a (S)AE occurs, a report has to be filed and
sent to the study coordination at the UMR.
DISCUSSION
We expect that in arm I (CBT), the parents will improve through
treatment as will their children (2, 7, 12). Since, parenting skills
of parents with a mental illness are likely impaired and enhancing
such skills leads to better child outcomes (17, 18, 20, 27, 28), we
expect that additional incremental effects will become apparent
in arm II (CBT+Triple P). We will use the Positive Parenting
Program (Triple P) in addition to CBT, as Triple P is an evidence-
based, widely used, and well-established program. The positive
effects of Triple P have been demonstrated in parents and
children (22, 23, 78), although incremental effects above and
beyond parental CBT have not been researched in conjunction
with COPMI so far.
The established magnitude of this specific incremental effect
will result in precise recommendations for this high-risk group
that will impact clinical practice (i.e., practice parameters,
treatment guidelines). As outlined above, COPMI are most likely
to constitute the next generation of patients with a mental illness,
and we assume that this intervention will contribute to the
prevention of SMI in this specific high-risk group.
As studies so far have focused primarily on specific disorders
(e.g., anxiety, depression) and have excluded comorbidities (1, 3),
though comorbidities actually occur with the most patients, the
COMPARE study will fill this research gap by including a broad
range of mental disorders and by not excluding comorbidities. A
double baseline measurement with multiple baselines depending
on the usual waiting periods in the study centers (T1: 1st
assessment of parents and children via clinical interviews and
questionnaires; T2: 2nd assessment with the same instruments)
will enable us to assess parental disorder effects on the child
that can then be related to parental treatment effects (T3: after
completion of 25 short-term to 45 long-term sessions of state-of-
the-art CBT or CBT+TripleP) for a 6-month follow-up (T4). As
there are differential parental psychotherapy effects on children
depending on the parental remission status (early, late, and non-
remitters), we will also assess such effects (9, 13). By including
different therapy durations (short- vs. long-term therapy) we will
be able to shed light on treatment duration effects.
Research and Clinical Implications
The RCT is part of the COMPARE consortium [see Christiansen
et al. (79) in this research topic] with the subprojects COMPARE-
emotion, COMPARE-interaction, COMPARE-work, and
COMPARE-school. The findings of the Compare consortium
will not only allow for the estimation of parental treatment
and parenting skill effects on their children, but also for
the novel approach of testing the core assumptions of the
transgenerational transmission of mental disorders model (5)
comprehensively. The cost-effectiveness and cost-utility analyses
from a societal and a health care system perspective will be a basis
for negotiations with health care providers, as COPMI at risk
can currently not receive professional help, except if they have
already developed disorders themselves. The evidence of this
trial will hopefully contribute to an understanding of preventing
the development of disorders in COMPI to reach this goal. The
identification of specific risk profiles will contribute to such an
improved understanding and will result in tailored interventions
that might either be more preventive or interventive in character,
depending on the individual risk.
Limitations
COMPARE-family plans four extensive assessments for all family
members as well as up to 55 therapy assessments. Even though
the majority of patients has positive attitudes toward extensive
diagnostic assessments (80), this might also be a burden on
the family, especially as the add-on projects require additional
assessments at the same assessment times.
Frontiers in Psychiatry | www.frontiersin.org 11 February 2019 | Volume 10 | Article 54
Stracke et al. COMPARE Family: Study Protocol
The implementation of a self-wait control design in the
RCT was originally planned with a waiting period of 6 months
between the first assessment of the patients and their families
and the beginning of the therapy. Due to the new psychotherapy
guidelines in Germany, that became effective in April 2017,
the waiting periods to receive psychotherapy treatment have
decreased enormously at the study sites. Although the time span
to receive a place in a treatment program can still be up to 9
months, many of the recruiting outpatient clinics have tried to
cut those time spans down (e.g., 1–3 months waiting periods).
With the original 6 months waiting period, patients wanting to
participate in the COMPARE study would consequently have had
to wait longer for their psychotherapy treatment than necessary.
For the study centers this not only created ethical but also
practical issues with interested patients preferring treatments
with shorter waiting periods to the participation in COMPARE.
With the now implemented multiple baseline design, the waiting
period can vary between the study centers depending on the
usual waiting periods on-site, therefore not disadvantaging
study participants.
The observation period of only 39 months in total is rather
short for capturing effects on the prevention of SMI, but due to
funding, a longer observation period could not be implemented.
For assessing long-term effects, a follow-up study is already
planned and all participants are asked permission to be contacted
again later on.
The majority of outpatient clinics will most likely treat
patients with depressive and affective disorders, a fact possibly
hampering the aim of the COMPARE study to cover a
broad range of disorders. However, as all outpatient clinics
are university-based and all recruiting centers have different
research foci, chances are good that the range of disorders
will be represented. This will also raise the generalizability
of findings.
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